|
 |
Now
Available as Part of CHI's
Network of Approved
Reports |
 |
|
|
|
-About Burrill
& Company
|
|
Burrill & Company is a life
sciences merchant bank focused exclusively on companies involved
in biotechnology, pharmaceuticals, diagnostics, devices, human
healthcare and related medical technologies, nutraceuticals and
wellness, agricultural biotechnology, and industrial biotechnology
(biomaterials/bioprocesses) with over $500 million under
management. Burrill's technical and venture investing competence
spans the entire spectrum of life sciences. The expertise of the
firm's investment team, strategic partners and Advisory Boards is
unparalleled in depth and breadth. In addition, Burrill is a
leader in life science strategic partnering, an invaluable
practice to build value in portfolio companies and to accelerate
their growth and development. Burrill is also the sponsor and
facilitator of three leading annual industry conferences and
publishes the seminal annual report on the state of the
biotechnology industry. This combination of resources and
capabilities has helped Burrill develop a unique and highly
effective platform for finding and making outstanding life science
investments.
|
|
|
|
*Discount does not
apply to reports already purchased. The prices quoted above
reflect the 10% discount.
|
|